Livzon Pharmaceutical Group Inc.

Related records

Trials (32)

• A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding
• A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis
• A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5
• A Study to Evaluate the Efficacy and Safety of LZM012
• A Study to Evaluate the Efficacy and Safety of LZM012 ( Psoriasis )
• Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
• Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH
• Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization
• DBM-1152A Inhalation Solution in Chinese Healthy Subjects
• DBM-1152A Inhalation Solution in Healthy Volunteers
• Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori
• Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection
• Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351
• IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
• Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
• Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients
• Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)
• Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)
• Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients
• Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients